Dexcom shares plunge after cautious 2026 outlook, despite strong Q3 results, as analysts cite margin pressure and uncertainty around G7 sensor uptake and accuracy.
Dexcom shares plunge after cautious 2026 outlook, despite strong Q3 results, as analysts cite margin pressure and uncertainty around G7 sensor uptake and accuracy.